Novo Nordisk said on Wednesday it is aware of 10 deaths and 100 hospitalizations resulting from people taking compounded copies of its weight-loss and diabetes drugs, and the CEO said he is alarmed by ...

Wegovy and Ozempic, both known chemically as semaglutide, were until recently in shortage in the US Although all dose ...

A DAD died after taking a weight loss jab for just a few weeks. Tim Ramsay, from South Australia, wanted to shed some pounds so he could confidently walk his daughter down the aisle. The ...

GLP-1 agonist Wegovy (semaglutide) brought in DKK 17.3 billion ($2.49 billion) in the period, restoring earlier levels of ...

Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted ...

Novo Nordisk (NVO) is aware of 10 deaths and 100 hospitalizations of people that took copycat versions of its popular drugs ...

Novo Nordisk latest news, photos, videos, breaking news, special reports, blogs, and updates from Business Insider India ...

But this fairly new diabetes drug seems to have a few more tricks up its sleeve. New research has found that Ozempic (or ...

Ever since their rise in popularity as weight loss drugs, there’s been a slew of reports on the potential adverse health ...

With ocedurenone gone, the only CKD program still listed in Novo’s pipeline is semaglutide—the main ingredient behind ...

Novo Nordisk's valuation remains high, trading at a significant historical premium. Click here to see why NVO stock is a Sell ...

While Ozempic has been shown to lead to weight loss as a side effect, it's not without risks. According to the Cleveland ...